Darbepoetin alfa (Aranesp™) in children with chronic renal failure

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

An alcoholic patient with recurrent renal failure and proteinuria T. Kumagai, Y. Hori, G. Seki, Toshiro Fujita Kidney International Volume 70, Issue 8,

Home care assistance and the utilization of peritoneal dialysis

Volume 54, Issue 4, Pages (October 1998)

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Stem cells for kidney repair: useful tool for acute renal failure?

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Progression of renal failure and hypertensive nephrosclerosis

Burden of chronic kidney disease: North Africa

Volume 54, Issue 2, Pages (August 1998)

Volume 62, Issue 2, Pages (August 2002)

Volume 66, Issue 3, Pages (September 2004)

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Enlightenment on liver lanthanum exposure

Late referral and modality choice in end-stage renal disease

Charles R. Nolan, Wajeh Y. Qunibi Kidney International

Volume 80, Issue 8, Pages (October 2011)

Volume 70, Issue 12, Pages (December 2006)

Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Volume 59, Issue 4, Pages (April 2001)

Volume 70, Issue 7, Pages (October 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 82, Issue 1, Pages 3-4 (July 2012)

The third World Kidney Day: Looking back and thinking forward

Alfonso M. Cueto-Manzano, Héctor R

Volume 66, Issue 2, Pages (August 2004)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Volume 74, Issue 8, Pages (October 2008)

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 71, Issue 4, Pages (February 2007)

Volume 80, Issue 3, Pages (August 2011)

Volume 59, Issue 6, Pages (June 2001)

Volume 54, Issue 4, Pages (October 1998)

Volume 73, Issue 9, Pages (May 2008)

Volume 77, Issue 6, Pages (March 2010)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Dialysis dose and gender: A different hypothesis

Dosing darbepoetin alfa

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Does equal care give equal outcomes?

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Robert G. Nelson, Hal Morgenstern, Peter H. Bennett

American Indian heritage and risk factors for renal injury

Volume 57, Issue 2, Pages (October 2000)

Is complement a target for therapy in renal disease?

Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Volume 62, Issue 6, Pages (December 2002)

Volume 62, Issue 5, (November 2002)

D.J. Askenazi, D.I. Feig, N.M. Graham, S. Hui-Stickle, S.L. Goldstein

Volume 57, Issue 2, Pages (October 2000)

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

The Ebf1 knockout mouse and glomerular maturation

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Darbepoetin alfa (Aranesp™) in children with chronic renal failure Denis F. Geary, Laura E. Keating, Annette Vigneux, Derek Stephens, Diane Hébert, Elizabeth A. Harvey Kidney International Volume 68, Issue 4, Pages 1759-1765 (October 2005) DOI: 10.1111/j.1523-1755.2005.00592.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Shown is the hemoglobin levels for all 33 children throughout the study. The dashed lines indicate the upper and lower target values for hemoglobin. Circles (C) represent the PD group, stars (*) represent the HD group, and diamonds (♦) represent the CRI group. The means for all three groups are also plotted. Kidney International 2005 68, 1759-1765DOI: (10.1111/j.1523-1755.2005.00592.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Illustrated are the dosing intervals in days for darbepoetin alfa at baseline, week 12 and week 28. Kidney International 2005 68, 1759-1765DOI: (10.1111/j.1523-1755.2005.00592.x) Copyright © 2005 International Society of Nephrology Terms and Conditions